Baxter International Inc.
Revenue Breakdown
| Fiscal Year | Renal | Hospital Products | Americas | EMEA | APAC | Hillrom | Medical Products and Therapies | Healthcare Systems and Technologies | Pharmaceuticals | Kidney Care | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2017 | — | — | $5.72B | $2.73B | $2.11B | — | — | — | — | — | — |
| FY2018 | — | — | $5.96B | $2.96B | $2.21B | — | — | — | — | — | — |
| FY2019 | — | — | $6.09B | $2.97B | $2.30B | — | — | — | — | — | — |
| FY2020 | — | — | $6.07B | $3.13B | $2.48B | — | — | — | — | — | — |
| FY2021 | — | — | $6.67B | $3.12B | $2.79B | $212.0M | — | — | — | — | — |
| FY2022 | — | — | $6.71B | $2.88B | $2.59B | $2.94B | — | — | — | — | — |
| FY2023 | — | — | — | — | — | — | $5.01B | $3.01B | $2.25B | $4.45B | $87.0M |
| FY2024 | — | — | — | — | — | — | $5.21B | $2.95B | $2.41B | — | $67.0M |
| FY2025 | — | — | — | — | — | — | $5.30B | $3.07B | $2.49B | — | $381.0M |